No photo of Frank Dieter Eckerdt

View Scopus Profile

Frank Dieter Eckerdt

  • 1143 Citations
20022019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Training Experience

2004Postdoctoral Fellowship, J. W. Goethe University

Education/Academic qualification

PhD, J. W. Goethe University

… → 2003

Fingerprint Dive into the research topics where Frank Dieter Eckerdt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Development of Novel MNK Inhibitors for Treating Glioblastoma

Clutter, M., Eckerdt, F. D., Horbinski, C. M., James, C. D., Mishra, R. K., Platanias, L. C. & Schiltz, G. E.

National Institute of Neurological Disorders and Stroke

9/1/19 → 6/30/24

Project: Research project

    • Research Output

    • 1143 Citations
    • 25 Article
    • 3 Review article
    • 2 Comment/debate
    • 1 Short survey

    Inhibitory effects of SEL201 in acute myeloid leukemia

    Kosciuczuk, E. M., Kar, A. K., Blyth, G. T., Fischietti, M., Abedin, S., Mina, A. A., Siliezar, R., Rzymski, T., Brzozka, K., Eklund, E. A., Beauchamp, E. M., Eckerdt, F., Saleiro, D. & Platanias, L. C., Jan 1 2019, In : Oncotarget. 10, 67, p. 7112-7121 10 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma

    Eckerdt, F., Clymer, J., Bell, J. B., Beauchamp, E. M., Blyth, G. T., Goldman, S. & Platanias, L. C., Dec 1 2019, In : Scientific reports. 9, 1, 12822.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Potent antineoplastic effects of combined PI3Kα-MNK inhibition in medulloblastoma

    Eckerdt, F., Bell, J. B., Beauchamp, E. M., Clymer, J., Blyth, G. T., Kosciuczuk, E. M., Ma, Q., Chen, D. Z., Horbinski, C., Goldman, S., Munshi, H. G., Hashizume, R. & Platanias, L. C., Jun 1 2019, In : Molecular Cancer Research. 17, 6, p. 1305-1315 11 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

    Brisard, D., Eckerdt, F., Marsh, L. A., Blyth, G. T., Jain, S., Cristofanilli, M., Horiuchi, D. & Platanias, L. C., Dec 1 2018, In : Oncotarget. 9, 99, p. 37305-37318 14 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Differential response of glioma stem cells to arsenic trioxide therapy is regulated by MNK1 and mRNA translation

    Bell, J. B., Eckerdt, F., Dhruv, H. D., Finlay, D., Peng, S., Kim, S., Kroczynska, B., Beauchamp, E. M., Alley, K., Clymer, J., Goldman, S., Cheng, S. Y., James, C. D., Nakano, I., Horbinski, C., Mazar, A. P., Vuori, K., Kumthekar, P., Raizer, J., Berens, M. E. & 1 others, Platanias, L. C., Jan 2018, In : Molecular Cancer Research. 16, 1, p. 32-46 15 p.

    Research output: Contribution to journal › Article

    • 11 Scopus citations